UBS Group’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-107
Closed -$4 10453
2023
Q3
$4 Buy
+107
New +$4 ﹤0.01% 9320
2023
Q2
Sell
-2,700
Closed -$95 10119
2023
Q1
$95 Sell
2,700
-38,837
-93% -$2.41K ﹤0.01% 9252
2022
Q4
$3.32K Buy
+41,537
New +$5.67K ﹤0.01% 9524

Other funds holding HLGN.WS

UBS Group's HLGN.WS Position: Q4 2023 in Review

UBS Group sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q4 2023, closing a stake of 107 shares — an estimated $4 sold.

UBS Group first reported a position in HLGN.WS in Q4 2022 and held it in 3 quarters. The position peaked at $3.32K in Q4 2022. 3 funds tracked by Wall St. Rank hold HLGN.WS as of Q4 2023.

  • UBS Group reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 107 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q4 2023, an estimated $4.
  • UBS Group first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q4 2022 and held it in 3 quarters.
  • UBS Group's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $3.32K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.